Georgia 2025-2026 Regular Session

Georgia Senate Bill SB162

Introduced
2/12/25  
Refer
2/13/25  
Report Pass
2/26/25  
Report Pass
3/3/25  
Engrossed
3/6/25  

Caption

Georgia Composite Medical Board; implement an automated credentialing system for healthcare providers in this state; provide

Impact

If enacted, SB162 will directly affect the licensure process for various healthcare professionals, requiring a streamlined approach aimed at reducing the time and complexity of securing credentials, particularly for those involved in psychedelic-assisted treatments. Each clinic providing these services will need to be licensed and will face regular renewals, ensuring continuous oversight and compliance with state-mandated standards. Additionally, the board must ensure that practitioners meet required competencies, fostering higher patient safety and care standards across the state.

Summary

SB162 aims to amend the Georgia Composite Medical Board's regulatory framework concerning healthcare providers, specifically focusing on the implementation of an automated licensure system and the regulation of psychedelic-assisted treatment and therapy. The bill mandates that by December 31, 2025, the board must establish rules and regulations that ensure consistent practices and promote patient safety for clinics that administer psychedelic treatments. The target substances include those that can induce alterations in perception and consciousness, with specific licensing and training requirements laid out for healthcare providers conducting such therapies.

Sentiment

The general sentiment surrounding SB162 appears nuanced. Proponents view the bill as a progressive step towards modernizing treatment options in Georgia, potentially increasing the availability of innovative therapeutic practices for mental health conditions. Conversely, there are concerns regarding the risks associated with psychedelic-assisted therapies, reflecting a more cautious outlook among opponents who call for careful regulation and thorough evaluation of their efficacy and safety before widespread adoption.

Contention

Key points of contention include the balance between innovation in mental health treatments and the need for rigorous oversight to ensure public safety. Critics argue that while the potential benefits of psychedelic treatments are promising, the lack of extensive long-term studies raises questions about safety, necessitating a cautious approach to implementation. Stakeholders may also debate the qualifications and training required for practitioners, emphasizing the importance of expertise in managing both the pharmacological and psychological aspects of these treatments.

Companion Bills

No companion bills found.

Previously Filed As

GA HB434

Georgia Composite Medical Board; licensing for radiologist assistants; provide

GA SB111

"Anesthesiologist Assistant Act"; an anesthesiologist assistant to be appointed in an advisory capacity to the Georgia Composite Medical Board; provide

GA HB155

Professions and businesses; issuance of licenses by endorsement for spouses of firefighters, healthcare providers, and law enforcement officers who relocate to Georgia; provide

GA SB481

Georgia Health Care Professionals Data System; establishment; definitions; collaboration with state licensing boards; provide

GA HB1046

Health; advanced practice registered nurses and physician assistants to order home healthcare services; authorize

GA HB163

Georgia Board of Health Care Workforce; student loan repayment for medical examiners employed by the Division of Forensic Sciences of the Georgia Bureau of Investigation; provide

GA SB238

Georgia Health Care Professionals Data System; provide for the establishment

GA SB12

"Protecting Victims and Dismantling Georgia Street Gangs Act"; enact

GA HB417

Insurance; prohibit insurers from discriminating against certain healthcare facilities and providers in connection with provider administered drugs

GA SB164

Nurses; licensure of advanced practice registered nurses; provide

Similar Bills

GA HB717

Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy; provide

CA SB803

Heal Our Heroes Act.

NC H727

Breakthrough Therapies Research/Advisory Act

NH HB1693

Relative to the use of psychedelics for therapeutic purposes.

CA AB941

Controlled substances: psychedelic-assisted therapy.

NV SJR10

Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801)

MD HB548

Task Force on Responsible Use of Natural Psychedelic Substances

MA S1400

Authorizing a pilot for the use of psychedelics in licensed treatment facilities